Transdigm (TDG) Tops Q4 EPS by 19c

Transdigm (NYSE: TDG) reported Q4 EPS of $2.21, $0.19 better than the analyst estimate of $2.02. Revenue for the quarter came in at $642.2 million versus the consensus estimate of $631.54 million.

Transdigm sees FY2014 EPS of $8.03-$8.29, versus the consensus of $7.58. Transdigm sees FY2014 revenue of $2.51-2.55 billion, versus the consensus of $2.36 billion.

For earnings history and earnings-related data on Transdigm (TDG) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Stardust Power (SDST) Tops Q2 EPS by 1c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c